Archive | Andrew Conrad of Autism Speaks | #AutisticHistory #StopBigAutism #BanABA

#NotAnAutisticAlly Andrew Conrad of Autism Speaks Andrew Conrad Chief Scientific OfficerCo-founder, LabCorp's National Genetic Institute Andrew Conrad, Ph.D. is the co-founder and Chief Scientific Officer of LabCorp's National Genetics Institute. Dr. Conrad graduated with a B.S. in neurobiology and a Ph.D. in cell biology from the University of California Los Angeles. He has served as …

Snapshot | Google alerts – autism | Circa January 7, 2018

autismDaily update ⋅ January 7, 2018NEWS Autism Rates Appear to Have Finally Plateaued in The US, But Doctors Don't Know WhyScienceAlertBased on surveys of more than 30,000 parents, the number of children with autism spectrum disorder (ASD) was 2.41 percent in the US between 2014 and 2016, with no statistically significant increase across that time. However, the new estimate from the …

SynapDx Corporation Timeline | Circa 2010 – 2017 #NotAnAutisticAlly #AutisticHistory

About SynapDx Corp. “SynapDx is a private company providing laboratory diagnostics to physicians who suspect children of developmental disorders, with the initial goal of enabling earlier detection of autism spectrum disorders (ASDs). The company collaborates with ASD and gene expression experts at leading institutions, including Boston Children’s Hospital. SynapDx was founded 2010 and is based in …

Archived | SynapDx Corporation Secures $15.4M in Funding Led by Google Ventures | Circa July 22, 2013 #NotAnAutisticAlly #AutisticHistory

SynapDx Corporation Secures $15.4M in Funding Led by Google Ventures Investment Propels Development of SynapDx’s Innovative Blood Test for the Early Diagnosis of AutismJuly 22, 2013 09:00 AM Eastern Daylight Time LEXINGTON, Mass.--(BUSINESS WIRE)--SynapDx Corporation, today announced it has secured a $15.4 million funding round, led by Google Ventures. Foundation Medical Partners also joined the financing as a …

Archived | Kraft Group backs autism test startup SynapDx, 3rd funding for firm since Dec. | Circa May 27, 2013 #NotAnAutisticAlly

Kraft Group backs autism test startup SynapDx, 3rd funding for firm since Dec. By Kyle Alspach   –  Technology Editor, Boston Business Journal Mar 27, 2013, 10:28am EDT The Kraft Group, owner of the New England Patriots and numerous other businesses, has made a "significant investment" into Southborough-based SynapDx, which is developing an early detection blood-based test for autism spectrum …

Archived | Featured Startup Pitch: Backed by some prominent investors, SynapDx is developing a test for significantly earlier Autism detection in children | Circa July 12, 2013 #NotAnAutisticAlly

Featured Startup Pitch: Backed by some prominent investors, SynapDx is developing a test for significantly earlier Autism detection in children July 12, 2013  StartUp BeatTM/ BRK Media, LLC.  Company: SynapDx Corporation Website: www.synapdx.com Video: http://www.vimeo.com/64564331 Headquarters: Lexington, Massachusetts Year Founded: 2010 Founders: Stanley Lapidus (President), Jeffrey Luber (VP, Corporate Development) Employees: 18 Investors: North Bridge Venture Partners, General Catalyst Partners, Laboratory Corporation of America, The …

Archived | SynapDx Corporation’s CEO Stanley Lapidus Presents at Autism Speaks’ Inaugural Autism Investment Conference | Circa February 21, 2013 #NotAnAutisticAlly

synapdx-press-release-autism-investment-conference-participation-updated-final-2-21-13Download Image promoting 2014 Autism Investment Conference by Autism Speaks March 4-5 2014. FOR IMMEDIATE RELEASE SynapDx Corporation’s CEO Stanley Lapidus Presents at Inaugural Autism Investment Conference Discusses Diagnostic Issues at Event Hosted by Autism Speaks Lexington, MA – February 21, 2013 – SynapDx Corporation is joining a select group of autism-focused companies to present …